ANN ARBOR, Mich., Sept. 25, 2025 /PRNewswire/ — Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announced today a distribution partnership to expand access to Akadeum’s next-generation cell isolation technology for cell and gene therapy development.
Under the agreement, Cayman will distribute Akadeum’s portfolio of buoyant microbubble cell isolation kits, integrating this groundbreaking platform into their extensive portfolio of products and services that support life science research and discovery.
Developed and manufactured at Akadeum’s headquarters in Ann Arbor, Michigan, the company’s microbubble-based cell isolation approach overcomes existing challenges of obtaining highly pure cell populations without compromising cell health, a critical early step in the development of cell and gene therapy applications.
As the first new cell separation modality in more than 40 years, Akadeum’s microbubble technology delivers a solution that is faster and gentler than traditional methods of separating cells from mixed populations. The kits feature simple protocols that easily integrate into existing workflows, yielding highly pure, isolated cell populations with improved recovery, high viability, and superior cell health.
Akadeum’s buoyant microbubble technology is a groundbreaking platform for cell isolation, and its partnership with Cayman marks an important step toward expanding access to the global research community. The collaboration is expected to empower researchers to drive progress across a wide range of fields, from advancing fundamental discoveries to enabling breakthroughs in cell and gene therapy.
“Cayman’s strong distribution network and reputation for delivering high-quality research tools make them an ideal partner for Akadeum Life Sciences,” said Brandon McNaughton, Ph.D., Akadeum’s CEO and Founder. “Through this partnership, scientists worldwide will have access to Akadeum’s microbubble technology, which provides a simpler, more effective method of cell separation that enhances purity, recovery, viability, and scalability.”
This distribution agreement highlights Cayman’s dedication to providing scientists with state-of-the-art technologies that help make research possible. Partnerships with pioneering companies like Akadeum strengthen Cayman’s standing among scientists as a trusted partner for advancing discovery across multiple disciplines.
Akadeum kits available through Cayman are for Research Use Only (RUO).
For more information, visit www.caymanchem.com/akadeum.
About Cayman
Cayman Chemical helps make research possible by providing products and services to scientists worldwide. Our collection includes high-quality biochemicals, assay kits, antibodies, and proteins, empowering researchers to understand the biological mechanisms of health and disease and develop new therapies. Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, and fatty acids, and we are highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination. In addition, we offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques. Cayman performs generic drug development and production in both Ann Arbor, Michigan and Neratovice, Czech Republic.
Learn more at www.caymanchem.com
About Akadeum
Akadeum Life Sciences is pioneering flotation-based separation technologies that enable more effective, scalable, and gentle cell isolation. As the first to commercialize flotation-based cell separation, Akadeum has introduced industry-first innovations—including scalable negative selection, multiplex separation, microbubble-based nucleic acid extraction, and the highest-capacity T cell separation chamber ever built. Driven by a mission to advance human health, Akadeum envisions a world where innovative separations empower researchers and clinicians to unlock breakthroughs in diagnostics, therapeutics, and basic research.
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-partnership-brings-next-generation-cell-isolation-solutions-to-researchers-advancing-cell-and-gene-therapy-development-302567440.html
SOURCE Cayman Chemical
